The absence of caveolin-1 increases proliferation and anchorage-independent growth by a rac-dependent, Erk-independent mechanism

Molecular and Cellular Biology

Volumn 29, Issue 18, 2009, Pages 5046-5059

  Cerezo, Ana ^a   Guadamillas, Marta C ^a   Goetz, Jacky G ^a   Sánchez Perales, Sara ^a   Klein, Eric ^b   Assoian, Richard K ^b   Del Pozo, Miguel A ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYCLIN D1; CYCLINE; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; RHO FACTOR; CHOLESTEROL; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INTEGRIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL CYCLE; CELL CYCLE PROGRESSION; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BIOLOGICAL MODEL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL TRANSFORMATION; ENZYME ACTIVATION; METABOLISM; PROTEIN TRANSPORT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CAVEOLIN 1; CELL ADHESION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHOLESTEROL; CYCLIN D1; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE; GLYCOGEN SYNTHASE KINASE 3; INTEGRINS; MEMBRANE MICRODOMAINS; MICE; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; RAC GTP-BINDING PROTEINS; RHO GTP-BINDING PROTEINS; S PHASE;

EID: 70249093948     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00315-09     Document Type: Article

References (65)

1. Assoian, R. K., and E. A. Klein. 2008. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol. 18:347-352.
2. Bar-Sagi, D., and A. Hall. 2000. Ras and Rho GTPases: a family reunion. Cell 103:227-238.
3. Beijersbergen, R. L., L. Carlee, R. M. Kerkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9:1340-1353.
4. Burridge, K., and K. Wennerberg. 2004. Rho and Rac take center stage. Cell 116:167-179. (Pubitemid 38167310)
5. Bustelo, X. R., V. Sauzeau, and I. M. Berenjeno. 2007. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29:356-370.
6. Classon, M., and N. Dyson. 2001. p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264:135-147. (Pubitemid 32989088)
7. Classon, M., and E. Harlow. 2002. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2:910-917. (Pubitemid 37328892)
8. Cobrinik, D. 2005. Pocket proteins and cell cycle control. Oncogene 24: 2796-2809. (Pubitemid 40638091)
9. del Pozo, M. A., N. B. Alderson, W. B. Kiosses, H. H. Chiang, R. G. Anderson, and M. A. Schwartz. 2004. Integrins regulate Rac targeting by internalization of membrane domains. Science 303:839-842.
10. del Pozo, M. A., N. Balasubramanian, N. B. Alderson, W. B. Kiosses, A. Grande-Garcia, R. G. Anderson, and M. A. Schwartz. 2005. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat. Cell Biol. 7:901-908.
11. del Pozo, M. A., L. S. Price, N. B. Alderson, X. D. Ren, and M. A. Schwartz. 2000. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J. 19:2008-2014.
12. del Pozo, M. A., M. Vicente-Manzanares, R. Tejedor, J. M. Serrador, and F. Sánchez-Madrid. 1999. Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. Eur. J. Immunol. 29:3609-3620.
13. Diehl, J. A., M. Cheng, M. F. Roussel, and C. J. Sherr. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511.
14. Diehl, J. A., F. Zindy, and C. J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
15. Drab, M., P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F. C. Luft, A. Schedl, H. Haller, and T. V. Kurzchalia. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452. (Pubitemid 32917325)
16. Engelman, J. A., C. C. Wykoff, S. Yasuhara, K. S. Song, T. Okamoto, and M. P. Lisanti. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272:16374-16381.
17. Engelman, J. A., X. L. Zhang, and M. P. Lisanti. 1998. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett. 436:403-410.
18. Freedman, V. H., and S. I. Shin. 1974. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3:355-359.
19. Frisch, S. M., and R. A. Screaton. 2001. Anoikis mechanisms. Curr. Opin. Cell Biol. 13:555-562.
20. Galbiati, F., D. Volonte, J. A. Engelman, G. Watanabe, R. Burk, R. G. Pestell, and M. P. Lisanti. 1998. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17:6633-6648. (Pubitemid 28521797)
21. Gladden, A. B., and J. A. Diehl. 2005. Location, location, location: the role of cyclin D1 nuclear localization in cancer. J. Cell. Biochem. 96:906-913. (Pubitemid 41688717)
22. Goetz, J. G., P. Lajoie, S. M. Wiseman, and I. R. Nabi. 2008. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev. 27:715-735.
23. Gonzalez, E., A. Nagiel, A. J. Lin, D. E. Golan, and T. Michel. 2004. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J. Biol. Chem. 279:40659-40669. (Pubitemid 39287660)
24. Gonzalez-Munoz, E., C. Lopez-Iglesias, M. Calvo, M. Palacin, A. Zorzano, and M. Camps. 2009. Caveolin-1 loss-of-function accelerates GLUT4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology 150:3493-3502.
25. Grande-García, A., A. Echarri, J. de Rooij, N. B. Alderson, C. M. Waterman-Storer, J. M. Valdivielso, and M. A. del Pozo. 2007. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J. Cell Biol. 177:683-694. (Pubitemid 46799839)
26. Han, S. E., K. H. Park, G. Lee, Y. J. Huh, and B. M. Min. 2004. Mutation and aberrant expression of caveolin-1 in human oral squamous cell carcinomas and oral cancer cell lines. Int. J. Oncol. 24:435-440.
27. Hancock, J. F. 2006. Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 7:456-462.
28. Hayashi, K., S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaguchi. 2001. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61:2361-2364. (Pubitemid 32685805)
29. Hirsch, E., L. Barberis, M. Brancaccio, O. Azzolino, D. Xu, J. M. Kyriakis, L. Silengo, F. G. Giancotti, G. Tarone, R. Fassler, and F. Altruda. 2002. Defective Rac-mediated proliferation and survival after targeted mutation of the beta1 integrin cytodomain. J. Cell Biol. 157:481-492. (Pubitemid 34839811)
30. Jacobson, K., O. G. Mouritsen, and R. G. Anderson. 2007. Lipid rafts: at a crossroad between cell biology and physics. Nat. Cell Biol. 9:7-14. (Pubitemid 46024188)
31. Jay, S. M., E. Skokos, F. Laiwalla, M. M. Krady, and T. R. Kyriakides. 2007. Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. Am. J. Pathol. 171:632-640.
32. Kiess, M., R. M. Gill, and P. A. Hamel. 1995. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ. 6:1287-1298.
33. Klein, E. A., Y. Yung, P. Castagnino, D. Kothapalli, and R. K. Assoian. 2007. Cell adhesion, cellular tension, and cell cycle control. Methods Enzymol. 426:155-175.
34. Koleske, A. J., D. Baltimore, and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92:1381-1385.
35. Lee, S. W., C. L. Reimer, P. Oh, D. B. Campbell, and J. E. Schnitzer. 1998. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16:1391-1397. (Pubitemid 28151846)
36. Le Lay, S., and T. V. Kurzchalia. 2005. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim. Biophys. Acta 1746:322-333. (Pubitemid 41815026)
37. Li, J., B. A. Ballif, A. M. Powelka, J. Dai, S. P. Gygi, and V. W. Hsu. 2005. Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration. Dev. Cell 9:663-673. (Pubitemid 41555148)
38. Martin, K. H., J. K. Slack, S. A. Boerner, C. C. Martin, and J. T. Parsons. 2002. Integrin connections map: to infinity and beyond. Science 296:1652-1653.
39. Martinez-Gac, L., M. Marques, Z. Garcia, M. R. Campanero, and A. C. Carrera. 2004. Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol. Cell. Biol. 24:2181-2189. (Pubitemid 38248955)
40. Mayor, S., and R. E. Pagano. 2007. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8:603-612.
41. Mettouchi, A., S. Klein, W. Guo, M. Lopez-Lago, E. Lemichez, J. K. Westwick, and F. G. Giancotti. 2001. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol. Cell 8:115-127.
42. Murata, T., M. I. Lin, Y. Huang, J. Yu, P. M. Bauer, F. J. Giordano, and W. C. Sessa. 2007. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J. Exp. Med. 204:2373-2382. (Pubitemid 47529323)
43. Parton, R. G., and K. Simons. 2007. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8:185-194.
44. Razani, B., J. A. Engelman, X. B. Wang, W. Schubert, X. L. Zhang, C. B. Marks, F. Macaluso, R. G. Russell, M. Li, R. G. Pestell, D. Di Vizio, H. Hou, Jr., B. Kneitz, G. Lagaud, G. J. Christ, W. Edelmann, and M. P. Lisanti. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276:38121-38138. (Pubitemid 33730533)
45. Ridley, A. J. 2001. Cyclin' round the cell with Rac. Dev. Cell 1:160-161.
46. Sahai, E., and C. J. Marshall. 2002. Rho-GTPases and cancer. Nat. Rev. Cancer 2:133-142.
47. Salanueva, I. J., A. Cerezo, M. C. Guadamillas, and M. A. del Pozo. 2007. Integrin regulation of caveolin function. J. Cell. Mol. Med. 11:969-980.
48. Scheel, J., J. Srinivasan, U. Honnert, A. Henske, and T. V. Kurzchalia. 1999. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat. Cell Biol. 1:127-129. (Pubitemid 129501956)
49. Schwartz, M. A., and M. H. Ginsberg. 2002. Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 4:E65-E68.
50. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
51. Sun, A., L. Bagella, S. Tutton, G. Romano, and A. Giordano. 2007. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J. Cell. Biochem. 102:1400-1404. (Pubitemid 350223943)
52. Sunaga, N., K. Miyajima, M. Suzuki, M. Sato, M. A. White, R. D. Ramirez, J. W. Shay, A. F. Gazdar, and J. D. Minna. 2004. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 64:4277-4285. (Pubitemid 38802434)
53. Tagawa, A., A. Mezzacasa, A. Hayer, A. Longatti, L. Pelkmans, and A. Helenius. 2005. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J. Cell Biol. 170: 769-779. (Pubitemid 41242109)
54. Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426. (Pubitemid 29180374)
55. Thompson, T. C., T. L. Timme, L. Li, and A. Goltsov. 1999. Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer. Apoptosis 4:233-237.
56. Valasek, M. A., J. Weng, P. W. Shaul, R. G. Anderson, and J. J. Repa. 2005. Caveolin-1 is not required for murine intestinal cholesterol transport. J. Biol. Chem. 280:28103-28109.
57. Villanueva, J., Y. Yung, J. L. Walker, and R. K. Assoian. 2007. ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol. Biol. Cell 18:1457-1463. (Pubitemid 46626640)
58. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
59. Welsh, C. F., K. Roovers, J. Villanueva, Y. Liu, M. A. Schwartz, and R. K. Assoian. 2001. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat. Cell Biol. 3:950-957.
60. Wiechen, K., C. Sers, A. Agoulnik, K. Arlt, M. Dietel, P. M. Schlag, and U. Schneider. 2001. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158:833-839. (Pubitemid 32221776)
61. Williams, T. M., M. W. Cheung, D. S. Park, B. Razani, A. W. Cohen, W. J. Muller, D. Di Vizio, N. G. Chopra, R. G. Pestell, and M. P. Lisanti. 2003. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Biol. Cell 14:1027-1042.
62. Williams, T. M., and M. P. Lisanti. 2005. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell. Physiol. 288:C494-C506.
63. Yang, G., T. L. Timme, A. Frolov, T. M. Wheeler, and T. C. Thompson. 2005. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer 103:1186-1194. (Pubitemid 40328089)
64. Yu, J. Y., J. Taylor, S. L. DeRuiter, A. B. Vojtek, and D. L. Turner. 2003. Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol. Ther. 7:228-236.
65. Zhang, W., B. Razani, Y. Altschuler, B. Bouzahzah, K. E. Mostov, R. G. Pestell, and M. P. Lisanti. 2000. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J. Biol. Chem. 275:20717-20725. (Pubitemid 30457660)